Comparative evaluation of the effects of platelet‑rich plasma formulations on extracellular matrix formation and the NF‑κB signaling pathway in human articular chondrocytes

Yin,Wenjing; Xu,Haitao; Sheng,Jiagen; Xu,Zhengliang; Xie,Xuetao; Zhang,Changqing

doi:10.3892/mmr.2017.6365

Comparative evaluation of the effects of platelet‑rich plasma formulations on extracellular matrix formation and the NF‑κB signaling pathway in human articular chondrocytes

Authors:
- Wenjing Yin
- Haitao Xu
- Jiagen Sheng
- Zhengliang Xu
- Xuetao Xie
- Changqing Zhang
View Affiliations

Affiliations: Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: March 23, 2017 https://doi.org/10.3892/mmr.2017.6365
Pages: 2940-2948
Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Concentrated leukocytes in leukocyte and platelet‑rich plasma (L‑PRP) may deliver increased levels of pro‑inflammatory cytokines to activate the nuclear factor (NF)‑κB signaling pathway, to counter or overwhelm the beneficial effects of growth factors on cartilage regeneration. However, to date, no relevant studies have substantiated this. In the present study, L‑PRP and pure platelet‑rich plasma (P‑PRP) were prepared, and leukocytes, platelets, pro‑inflammatory cytokines and growth factor concentrations were quantified; they were then used to treat human articular chondrocytes (HACs). Pyrrolidine dithiocarbamate (PDTC; 50 µM) was used to inhibit the activation of NF‑κB. The nuclear translocation of NF‑κB p65 and the protein expression of cartilaginous markers (collagen II, aggrecan and sex‑determining region Y‑box 9) were determined using western blot analysis. The mRNA expression of NF‑κB‑dependent inflammatory mediators, including inducible nitric oxide synthase and cyclooxygenase‑2, and cartilaginous markers were determined using reverse transcription‑quantitative polymerase chain reaction analysis. The production of prostaglandin E2, nitric oxide and glycosaminoglycan (GAG) were quantified using enzyme‑linked immunosorbent assays, the Griess reaction and a 1,9‑dimethylmethylene blue assay, respectively. The results demonstrated that L‑PRP induced the nuclear translocation of NF‑κB p65, upregulated the mRNA expression of NF‑κB‑dependent inflammatory mediators and upregulated the production of their products, whereas P‑PRP, which had similar growth factor concentrations but significantly lower pro‑inflammatory cytokine concentrations than L‑PRP, did not. P‑PRP promoted the mRNA and protein expression levels of cartilaginous markers and the production of GAG more effectively, compared with L‑PRP. Furthermore, inhibition of the activation of NF‑κB by PDTC enhanced the effects of L‑PRP on extracellular matrix formation in the HACs to a level similar to that of P‑PRP. These findings suggested that leukocytes in L‑PRP activated the NF‑κB signaling pathway via the delivery of interleukin‑1β and tumor necrosis factor‑α to counter the beneficial effects of growth factors on extracellular matrix formation in HACs. Therefore, P‑PRP may be more suitable for the treatment of osteoarthritis.

View Figures

View References

1	Woolf AD and Pfleger B: Burden of major musculoskeletal conditions. Bull World Health Organ. 81:646–656. 2003.PubMed/NCBI
2	FitzGerald GA and Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 345:433–442. 2001. View Article : Google Scholar : PubMed/NCBI
3	Altman RD and Moskowitz R: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 25:2203–2212. 1998.PubMed/NCBI
4	Muir H: The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays. 17:1039–1048. 1995. View Article : Google Scholar : PubMed/NCBI
5	Castillo TN, Pouliot MA, Kim HJ and Dragoo JL: Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 39:266–271. 2011. View Article : Google Scholar : PubMed/NCBI
6	Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, Magalon G, Dignat-Georges F and Sabatier F: Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 30:629–638. 2014. View Article : Google Scholar : PubMed/NCBI
7	Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, Fornasari PM, Giannini S and Marcacci M: Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy. 27:1490–1501. 2011. View Article : Google Scholar : PubMed/NCBI
8	Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, Fornasari PM, Giannini S and Marcacci M: Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 19:528–535. 2011. View Article : Google Scholar : PubMed/NCBI
9	Ehrenfest Dohan DM, Rasmusson L and Albrektsson T: Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 27:158–167. 2009. View Article : Google Scholar : PubMed/NCBI
10	Sundman EA, Cole BJ and Fortier LA: Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 39:2135–2140. 2011. View Article : Google Scholar : PubMed/NCBI
11	Burguera EF, Vela-Anero A, Magalhaes J, Meijide-Failde R and Blanco FJ: Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1β-stimulated human articular chondrocytes. Osteoarthritis Cartilage. 22:1026–1035. 2014. View Article : Google Scholar : PubMed/NCBI
12	Campbell KA, Minashima T, Zhang Y, Hadley S, Lee YJ, Giovinazzo J, Quirno M and Kirsch T: Annexin A6 interacts with p65 and stimulates NF-kB activity and catabolic events in articular chondrocytes. Arthritis Rheum. 65:3120–3129. 2013. View Article : Google Scholar : PubMed/NCBI
13	Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum. 29:1039–1049. 1986. View Article : Google Scholar : PubMed/NCBI
14	Cavallo C, Filardo G, Mariani E, Kon E, Marcacci M, Ruiz Pereira MT, Facchini A and Grigolo B: Comparison of platelet-rich plasma formulations for cartilage healing: An in vitro study. J Bone Joint Surg Am. 96:423–429. 2014. View Article : Google Scholar : PubMed/NCBI
15	Zhu H, Cheng X, Niu X, Zhang Y, Guan J, Liu X, Tao S, Wang Y and Zhang C: Proton-sensing GPCR-YAP signalling promotes cell proliferation and survival. Int J Biol Sci. 11:1181–1189. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zhi Y, Duan Y, Zhou X, Yin X, Guan G, Zhang H, Dong Q and Yang K: NF-kB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4. Med Sci Monit. 20:2746–2752. 2014. View Article : Google Scholar : PubMed/NCBI
17	Mladenova D, Pangon L, Currey N, Ng I, Musgrove EA, Grey ST and Kohonen-Corish MR: Sulindac activates NF-kB signaling in colon cancer cells. Cell Commun Signal. 11:732013. View Article : Google Scholar : PubMed/NCBI
18	de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA and van Osch GJ: Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 36:1171–1178. 2008. View Article : Google Scholar : PubMed/NCBI
19	McCarrel T and Fortier L: Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 27:1033–1042. 2009. View Article : Google Scholar : PubMed/NCBI
20	Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia W, Tuan RS and Zhang C: Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials. 33:7008–7018. 2012. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Heldin CH, Eriksson U and Ostman A: New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys. 398:284–290. 2002. View Article : Google Scholar : PubMed/NCBI
23	Yaeger PC, Masi TL, de Ortiz JL, Binette F, Tubo R and McPherson JM: Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res. 237:318–325. 1997. View Article : Google Scholar : PubMed/NCBI
24	Stewart K, Pabbruwe M, Dickinson S, Sims T, Hollander AP and Chaudhuri JB: The effect of growth factor treatment on meniscal chondrocyte proliferation and differentiation on polyglycolic acid scaffolds. Tissue Eng. 13:271–280. 2007. View Article : Google Scholar : PubMed/NCBI
25	Berg U, Gustafsson T, Sundberg CJ, Carlsson-Skwirut C, Hall K, Jakeman P and Bang P: Local changes in the insulin-like growth factor system in human skeletal muscle assessed by microdialysis and arterio-venous differences technique. Growth Horm IGF Res. 16:217–223. 2006. View Article : Google Scholar : PubMed/NCBI
26	Saklatvala J: Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 322:547–549. 1986. View Article : Google Scholar : PubMed/NCBI
27	Henderson B and Pettipher ER: Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol. 75:306–310. 1989.PubMed/NCBI
28	Bacconnier L, Jorgensen C and Fabre S: Erosive osteoarthritis of the hand: Clinical experience with anakinra. Ann Rheum Dis. 68:1078–1079. 2009. View Article : Google Scholar : PubMed/NCBI
29	Grunke M and Schulze-Koops H: Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis. 65:555–556. 2006. View Article : Google Scholar : PubMed/NCBI
30	Davidson RK, Jupp O, de Ferrars R, Kay CD, Culley KL, Norton R, Driscoll C, Vincent TL, Donell ST, Bao Y and Clark IM: Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum. 65:3130–3140. 2013. View Article : Google Scholar : PubMed/NCBI
31	Pereira RC, Scaranari M, Benelli R, Strada P, Reis RL, Cancedda R and Gentili C: Dual effect of platelet lysate on human articular cartilage: A maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng Part A. 19:1476–1488. 2013. View Article : Google Scholar : PubMed/NCBI
32	van Buul GM, Koevoet WL, Kops N, Bos PK, Verhaar JA, Weinans H, Bernsen MR and van Osch GJ: Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 39:2362–2370. 2011. View Article : Google Scholar : PubMed/NCBI
33	Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, Galera P and Boumediene K: Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res. 49:293–297. 2008. View Article : Google Scholar : PubMed/NCBI
34	Rédini F, Mauviel A, Pronost S, Loyau G and Pujol JP: Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum. 36:44–50. 1993. View Article : Google Scholar : PubMed/NCBI
35	Millan MJ: The induction of pain: An integrative review. Prog Neurobiol. 57:1–164. 1999. View Article : Google Scholar : PubMed/NCBI
36	Tegeder I, Niederberger E, Schmidt R, Kunz S, Guhring H, Ritzeler O, Michaelis M and Geisslinger G: Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 24:1637–1645. 2004. View Article : Google Scholar : PubMed/NCBI